ATM inhibition attenuates ferroptosis-associated injury and reduces infarct volume in experimental stroke
Ferroptosis and Oxidative Stress · 2026
DOI: 10.70401/fos.2026.0046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ferroptosis and Oxidative Stress, 2026. Verfasst von Han Kyu Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27705, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.
Themen: Schlaganfall
Abstract (Originalsprache)
Aims
Ferroptosis, an iron-dependent form of regulated cell death, contributes to neuronal injury after ischemic stroke. Because our previous cancer-cell screens identified ataxia-telangiectasia mutated (ATM) kinase, as a ferroptosis regulator, we investigated whether ATM inhibition protects neural tissue after ischemic stroke and examined determinants of therapeutic response.
Methods
ATM inhibitors, including the brain-penetrant clinical compound AZD1390, were evaluated in cultured cancer and neuronal cells, oxygen-glucose-deprived rat and mouse brain slices, and permanent middle cerebral artery occlusion models using multiple inbred and Rabep2-genotype mouse strains. Cell viability, cytotoxicity, lipid peroxidation, ferroptosis-associated markers, infarct volume, and collateral vessel density were assessed. Topical AZD1390 was also tested in mice with impaired collateral networks.
Results
ATM inhibition reduced ferroptosis-associated lipid oxidative injury and protected neurons in multiple preclinical stroke models. AZD1390 decreased lipid peroxidation and neuronal death, and reduced infarct volume in B6/J and B6/NJ mice, but not in BALB mice. Treatment efficacy varied among strains and was correlated with collateral vascular density. Systemic AZD1390 was likewise ineffective in Rabep2-knockout mice with deficient collateral networks. Early topical administration also reduced infarct volume in mice with limited collateral networks; however, differences in treatment timing and route preclude direct attribution to improved local drug delivery.
Conclusion
ATM inhibition may attenuate ferroptosis-associated neuronal injury after ischemic stroke, while collateral vascular anatomy may influence therapeutic response. These findings support further mechanistic and translational evaluation of ferroptosis-targeting strategies in stroke.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27705, USA.
- Duke Center for Genomic and Computational Biology, Duke University, Durham, NC 27705, USA.
- Department of Radiation Oncology, Duke University School of Medicine, Durham, NC 27705, USA.
Förderung
- NCATS NIH HHS
Zitieren
APA
Lee, H. K., Lin, C. C., Dunn, D. E., Chen, Y., Chen, S. Y., Marchuk, D. A., Floyd, S. R., & Chi, J. T. (2026). ATM inhibition attenuates ferroptosis-associated injury and reduces infarct volume in experimental stroke. Ferroptosis and Oxidative Stress. https://doi.org/10.70401/fos.2026.0046
Vancouver
Lee HK, Lin CC, Dunn DE, Chen Y, Chen SY, Marchuk DA, et al. ATM inhibition attenuates ferroptosis-associated injury and reduces infarct volume in experimental stroke. Ferroptosis and Oxidative Stress. 2026. doi:10.70401/fos.2026.0046
BibTeX
@article{Lee2026,
author = {Lee, Han Kyu and Lin, Chao-Chieh and Dunn, Denise E and Chen, Yubin and Chen, Ssu-Yu and Marchuk, Douglas A and Floyd, Scott R and Chi, Jen-Tsan},
title = {ATM inhibition attenuates ferroptosis-associated injury and reduces infarct volume in experimental stroke},
journal = {Ferroptosis and Oxidative Stress},
year = {2026},
doi = {10.70401/fos.2026.0046}
}
EUVIMED